ライフサイエンスコーパス: be offered to

1 Screening colonoscopy was offered to 1,500 healthy volunteers aged 50-65 years

2 ITx was offered to 10% of patients with <12 mo of remaining

3 MIP was offered to 100 selected consecutive patients during

4 Sodium stibogluconate was offered to 11 patients in the fluconazole group who

5 PSA testing was offered to 110,000 men aged 50 to 69 years from 2002

6 Bridge to ventricular assistance device was offered to 14% of patients, and 7% received a transp

7 -negative patients, SN biopsy would not have been offered to 22.1%, 13.4%, and 12.4% based on the MIA

8 Vaccination was offered to 45 individuals with an initial assessment

9 Penetrating keratoplasty was offered to 5 patients when improvement plateaued at

10 ing one fifth [0.1 ml] of the standard dose) was offered to 7.6 million children 2 years of age or ol

11 Access to two online curricula was offered to 75 surgical faculty and trainees from 12

12 Some type of surgery was offered to 78% of women in HICs and 56% of women in

13 program and non-surgical periodontal therapy were offered to 80 smokers with periodontitis.

14 cancer-related infertility and sperm banking was offered to 904 men diagnosed with cancer within the

15 option of avoiding initial radiotherapy can be offered to a broader group of women than current guid

16 ts suggest that early transplantation should be offered to a carefully selected group of patients wei

17 becomes possible, focal therapy will likely be offered to a considerable proportion of prostate canc

18 utilization and diminished survival, should be offered to a patient whose first allograft is failing

19 ic patients is also high, and it should only be offered to a small carefully selected cohort of sympt

20 SSRC is a promising new technique, which can be offered to a wide array of patients.

21 When a deceased-donor kidney is offered to a waitlisted candidate, the decision to ac

22 treatment groups, 4-session booster training was offered to a 60% random sample 11 months later.

23 Intervention (open or endovascular repair) was offered to a greater proportion of cases in the USA

24 In line with this, a unique opportunity was offered to a selected group of 16 representatives fr

25 cohorts of young girls, while in Norway this was offered to a single cohort only.

26 Until March 2018, liver grafts were offered to a center and allocated to a patient on t

27 e open-label phase, additional aTBS sessions were offered to achieve a response (>=50% HDRS-17 score

28 hought that incidental ES/WGS results should be offered to adult patients (85%), healthy adults (75%)

29 ation with messenger RNA (mRNA) vaccines has been offered to adults in England starting on 14 Septemb

30 Study enrollment was offered to adults aged 18 years or older in Los Ange

31 In addition, a research plan is offered to advance research by (a) understanding the

32 members preferred engagement modalities that are offered to all participants and allow them to share

33 Diagnostic tests should be offered to all at-risk relatives of X-ALD patients an

34 Genetic testing should be offered to all children diagnosed with sonic hedgehog

35 s of screening, and smoking cessation should be offered to all current smokers; that management of de

36 Device therapies should be offered to all eligible patients with heart failure,

37 ational clinical guidelines that ExCR should be offered to all HF patients.

38 has recommended that antiretroviral therapy be offered to all HIV-infected individuals with uninfect

39 Counseling about LHON should be offered to all maternal bloodline relatives, females

40 respondents agreed that sperm banking should be offered to all men at risk of infertility as a result

41 esting of cancer predisposition genes should be offered to all men with breast cancer.

42 BRCA1/2 mutation testing should be offered to all newly diagnosed patients with breast c

43 r SRMs is the standard treatment that should be offered to all patients for whom an intervention is i

44 al role in the first-line setting and should be offered to all patients who are eligible for systemic

45 roaches, we conclude that laparoscopy should be offered to all patients who lack an absolute contrain

46 Nowadays, platinum-based chemotherapy should be offered to all patients with a reasonable chance of r

47 The study findings suggest that PSO should be offered to all patients with BRCA1/2 breast cancer wh

48 social and/or psychosexual counseling should be offered to all patients with cancer, aiming to improv

49 egrated somatic and germline analysis should be offered to all patients with PDAC.

50 erally well-tolerated medication that should be offered to all patients with primary biliary cholangi

51 Treatment should usually be offered to all patients with symptoms ascribed to HIV

52 mity of opinion that surgical therapy should be offered to all patients, and comfort care continues t

53 radiotherapy dose for bone metastases should be offered to all patients, even those with poor surviva

54 Palliative care should be offered to all patients.

55 ; for physicians with Pt<35%, surgery should be offered to all patients; and for Pt values>70%, the l

56 CGM should be offered to all pregnant women with type 1 diabetes us

57 idisciplinary shared decision making, should be offered to all suitable candidates with muscle-invasi

58 SPK transplants should be offered to all suitable diabetic patients with renal

59 dation that germ-line BRCA1/2 testing should be offered to all women diagnosed with nonmucinous, ovar

60 tensin converting enzyme inhibitor ramipril, is offered to all participants.

61 time before germline multigene panel testing is offered to all patients with cancer; however, this ar

62 In 2013, se-SRP was offered to all available subjects from the original

63 Screening for HHC was offered to all employees of the Massachusetts Polaro

64 Treatment was offered to all HPV-positive women in Arm 1 and to VI

65 The questionnaire was offered to all mainstream schools, delivered by the

66 r an abnormal digital rectal examination and was offered to all men at the trial's end.

67 iometric hearing and speech-in-noise testing was offered to all participants at visit 6.

68 PrEP was offered to all participants in a prospective cohort

69 PrEP was offered to all participants in a prospective cohort

70 ervention, gonorrhea and chlamydia screening was offered to all participants, and clinical decision s

71 5N1 vaccine became available, one H5N1 boost was offered to all participants.

72 Behavioral support (Quitline) was offered to all participants.

73 One dose of azithromycin was offered to all residents of both intervention and co

74 A single dose of oral azithromycin was offered to all residents of the 8 selected villages

75 Serum transferrin saturation screening tests were offered to all adult patients in participating prim

76 Vaccines were offered to all employees and were coadministered or

77 tive therapy for hematologic malignancies to be offered to an expanded patient population.

78 B:9-23 peptide, but not the insulin protein, is offered to antigen presenting cells (APCs).

79 moderately hypofractionated radiotherapy can be offered to any patient for whole breast, chest wall (

80 Enrollment was offered to applicants randomly selected for 40 spots

81 llenging but rewarding procedure that should be offered to appropriate patients.

82 Sipuleucel-T may be offered to asymptomatic/minimally symptomatic men.

83 Open-label therapy was offered to autologous FMT participants at 8 weeks an

84 he new private health plan options that will be offered to beneficiaries, improvements made to tradit

85 lanning whether and how the procedure should be offered to broad groups of patients.

86 LAIV is offered to children across the world; however, its ef

87 ICIPANTS: Screening for islet autoantibodies was offered to children aged 1.75 to 5.99 years in Bavar

88 In 1995, vaccination was offered to children aged 2 to 12 years during vaccin

89 A simple mathematical model is offered to clarify how the timing of such a choice ca

90 These nomograms can be offered to clinicians to improve their abilities to a

91 Surgery with curative intent can be offered to congenital hyperinsulinism (CHI) patients,

92 Testing of germline SDH genes was offered to consenting patients and families.

93 12-month post-baseline assessment, and CETA was offered to control participants.

94 In the adult prison, study participation was offered to detained persons visiting the medical uni

95 on current documentation, a simplified rule is offered to direct resuscitators to treatable precipit

96 Device therapies should be offered to eligible heart failure patients, without m

97 ogous hematopoietic cell transplantation may be offered to eligible patients.

98 mptoms, and endovascular thrombectomy should be offered to eligible patients.

99 ne, and/or radical prostatectomy (RP) should be offered to eligible patients.

100 apy, brachytherapy boost (LDR or HDR) should be offered to eligible patients.

101 y boost (LDR or high-dose rate [HDR]) should be offered to eligible patients.

102 Live attenuated influenza vaccine (LAIV) was offered to eligible children in elementary schools o

103 A paper survey was offered to eligible patients on arrival for routine

104 (90)Y-FAPI-46 radioligand therapy was offered to eligible patients with progressive SFT.

105 ut very promising field; therefore, insights are offered to encourage more research and development.

106 Probabilistic approaches have been offered to enhance the algorithms, though existing

107 idered, ethical analysis and recommendations are offered to ensure the practice of UTx remains within

108 nes call for shared decision-making when LCS is offered to ensure informed, patient-centered decision

109 elines recommend that such pharmacotherapies be offered to everyone who wants to quit smoking.

110 are essential, and proper counseling should be offered to expectant mothers with regard to both the

111 Possible mechanistic insights are offered to explain the dual stereoselectivity observ

112 Mechanistic interpretations are offered to explain the observed reaction rates of th

113 Numerous potential mechanisms have been offered to explain these results, but research into

114 Many explanations have been offered to explain this anomaly, but none have prov

115 Various explanations have been offered to explain this apparent nonresponsiveness

116 Multiple hypotheses have been offered to explain this phenomenon.

117 Several mechanisms have been offered to explain transitive performance.

118 ion, a hypothesis based on a maternal effect was offered to explain the multigenerational carcinogene

119 Several communication tools are offered to facilitate exchange of information.

120 xcluded research presentations, of which 400 were offered to female participants (19.1%) across the s

121 easles-mumps-rubella (MMR) vaccinations have been offered to Finnish children at 14-18 months and 6 y

122 ection biases where less aggressive regimens are offered to frailer patients.

123 nd, UK, in Sept 1, 2008: routine vaccination was offered to girls aged 12-13 years with a catch-up pr

124 alent human papillomavirus (HPV) vaccination was offered to girls in the Netherlands.

125 (PABD), it is a procedure that continues to be offered to healthy living liver donor (LLD).

126 Three suggestions are offered to help reverse the situation: (1) stop radi

127 Adjuvant cisplatin-based chemotherapy may be offered to high-risk patients who have not received n

128 -nine years after his death, a state funeral was offered to his living family to honor his role in th

129 e was <10%, incentives were provided, or HBT was offered to household members of HIV-positive individ

130 ing for BMPR2 mutations is available and may be offered to HPAH and IPAH patients but should be prece

131 discussed, and examples of original research are offered to illustrate opportunities for the advancem

132 ntech, South San Francisco, California, USA) are offered to illustrate the current approval process a

133 Several recommendations are offered to improve the visibility and salience of cl

134 valuating new preventive approaches that can be offered to individuals at lower risk.

135 ation is effective and, if available, should be offered to individuals at risk of exposure to mpox.

136 Screening of the GJB2 mutation can be offered to individuals with congenital deafness with

137 Surgery is offered to individuals with trichiasis and antibiotic

138 A reduced two-dose priming schedule was offered to infants at 2 months and 4 months, alongsi

139 Our findings are offered to inspire the consideration of lectin-based

140 BA was offered to intervention participants (n = 47), and c

141 ent knowledge, we recommend that ICIs should be offered to kidney transplant recipients with advanced

142 Relaxation interventions can be offered to lactating parents who would like to increa

143 Pediatric End-Stage Liver Disease >15 before being offered to local/regional + circle non-status 1A a

144 Sperm cryopreservation should be offered to males before cancer-directed treatment, wi

145 Two composite endpoints are offered to meet this need.

146 care are effective for weight loss and could be offered to members of the public.

147 Immediate ADT may be offered to men who initially present with noncastrate

148 position; contralateral annual mammogram may be offered to men with a history of breast cancer and a

149 Ipsilateral annual mammogram should be offered to men with a history of breast cancer treate

150 Intermittent ADT may be offered to men with high-risk biochemically recurrent

151 Focal therapy should be offered to men with higher-risk disease either at bas

152 Active surveillance may be offered to men with low-risk biochemically recurrent

153 aterone, enzalutamide, or apalutamide should be offered to men with metastatic noncastrate prostate c

154 Prostate biopsies were offered to men with a PSA concentration of 3.0 mug/

155 s and meet these challenges, recommendations are offered to more comprehensively address gaps in our

156 Lungs that were eventually exported were offered to more US potential transplant recipients

157 incorporated into hepatology clinics and can be offered to most NASH patients.

158 Some oncologists have argued that BMT should be offered to most patients in first complete remission

159 Conversely, TAVR-explant can be offered to most patients who are surgical candidates,

160 h myelodysplastic syndromes, ESAs should not be offered to most patients with nonchemotherapy-associa

161 The influenza vaccine was offered to mothers and household members of neonates

162 In the first-line setting, HAIP could be offered to motivated patients who hope to achieve con

163 investigation by imaging from neck to pelvis was offered to mutation-positive registrants and their r

164 cation policies to allow pediatric organs to be offered to national children with status 1B or Model

165 oses of immunotherapy and targeted therapies be offered to obese adults with cancer.

166 t least 65 years of age it is less likely to be offered to older or nonwhite patients.

167 Surgery for Ebstein's anomaly can now be offered to older patients at low risk and with good l

168 Lung transplantation (LTx) is offered to older and more complex patients who may be

169 and convenient treatment modalities that can be offered to outpatients with MPE is set forth.

170 d determine which 2 self-sampling kits would be offered to participants in a pilot study.

171 l for appropriate clinical follow-up, should be offered to participants.

172 t liver-transplantation policy, donor organs are offered to patients with the highest risk of death.

173 omy, and several types of urinary diversions are offered to patients, with quality of life as an impo

174 s suggest that biweekly CBZ16 regimen should be offered to patients 65 years or older with mCRPC for

175 younger patient group, and these data should be offered to patients as part of the shared decision ma

176 en shown that continent diversion can safely be offered to patients at high risk for local recurrence

177 These therapies should be offered to patients at high risk for severe COVID-19

178 r and without active disease, testing should be offered to patients diagnosed <=65 years and selectiv

179 g number of novel treatment options that can be offered to patients faced with recurrent NMIBC after

180 port the recommendation that transplantation be offered to patients in the early stages of CCALD.

181 in the treatment of Bell's palsy and should be offered to patients presenting within 72 h of symptom

182 Antibiotic prophylaxis should be offered to patients receiving chemotherapy for acute

183 ill a subject of ongoing debate, SPLC should be offered to patients undergoing surgery for benign gal

184 Surveillance imaging may not be offered to patients who are clinically unsuitable for

185 Through technological advances, RRT can be offered to patients who are older and more frail.

186 definitive treatment with radioiodine should be offered to patients who are unlikely to achieve remis

187 sed on colonoscopy offered first, FIT should be offered to patients who decline colonoscopy.

188 Adjuvant chemoradiation may be offered to patients who did not receive preoperative

189 he PPI dose or switching to another PPI will be offered to patients who failed PPI once daily.

190 for CAMs for IBD so that rational advice can be offered to patients who inquire about their use.

191 Memantine and hippocampal avoidance should be offered to patients who receive whole brain radiation

192 it has been recommended that TAVR should not be offered to patients who will not improve functionally

193 BCI may be offered to patients with 0-3 positive nodes who recei

194 f TMLI to RIC is feasible and safe and could be offered to patients with advanced hematologic maligna

195 volumab alone, or pembrolizumab alone should be offered to patients with BRAF wild-type cutaneous mel

196 ESAs (including biosimilars) may be offered to patients with chemotherapy-associated anem

197 from colon cancer, this procedure should not be offered to patients with colon cancer.

198 itaxel (adequate comorbidity profile) should be offered to patients with Eastern Cooperative Oncology

199 file, and gemcitabine or fluorouracil should be offered to patients with either an ECOG PS 2 or a com

200 Revascularization continues to be offered to patients with evidence of myocardial viabi

201 rapy, gemcitabine plus NAB-paclitaxel should be offered to patients with first-line treatment with FO

202 inotecan, or nanoliposomal irinotecan should be offered to patients with first-line treatment with ge

203 sertive community training programs ought to be offered to patients with frequent relapses and hospit

204 Eradication therapy should be offered to patients with functional dyspepsia who tes

205 s of EP constitute effective therapy and can be offered to patients with good-risk GCT.

206 erative chemotherapy or surgery alone should be offered to patients with mCRC who are candidates for

207 nzyme Q10 supplementation should continue to be offered to patients with mitochondrial myopathies pen

208 Opioids should be offered to patients with moderate-to-severe pain rela

209 Concurrent TMZ and RT should be offered to patients with newly diagnosed glioblastoma

210 stereotactic radiosurgery (SRS) alone should be offered to patients with one to four unresected brain

211 SRS alone to the surgical cavity should be offered to patients with one to two resected brain me

212 py should be offered, or triplet therapy may be offered to patients with previously untreated, initia

213 Fulvestrant and a CDK4/6 inhibitor should be offered to patients with progressive disease during t

214 Treatment with a PARPi should be offered to patients with recurrent EOC that has not r

215 t setting, nivolumab or pembrolizumab should be offered to patients with resected stage IIIA/B/C/D BR

216 Continuous positive airway pressure should be offered to patients with severe OSA, whereas oral app

217 The addition of olaparib to bevacizumab may be offered to patients with stage III-IV EOC with g/sBRC

218 In particular, PSO should be offered to patients with the BRCA1 variant at the tim

219 Carboplatin may be offered to patients with TNBC to increase pathologic

220 s, near-total and total thyroidectomy should be offered to patients with well-differentiated carcinom

221 skipping mutations, and NTRK fusions should be offered to patients, either as initial or second-line

222 ns the only interventions that can currently be offered to patients.

223 A modified Fontan procedure has been offered to patients with a variety of complex cyano

224 Adjuvant therapy is offered to patients who are at a high risk of recurre

225 g either carotid endarterectomy or stenting, is offered to patients with carotid stenosis to prevent

226 ic cranial radiation (25 Gy in 10 fractions) was offered to patients for whom complete response (CR)

227 The FOCUS4-N trial was offered to patients in whom a targeted subtrial was

228 ing similar technique and 0.25% bupivacaine, was offered to patients undergoing liver tumoral ablatio

229 Intra-ophthalmic artery melphalan was offered to patients who had failed to respond adequa

230 Favipiravir treatment was offered to patients with EVD on a compassionate-use

231 The option of esophageal dilation was offered to patients with moderate to severe persiste

232 tin/doxorubicin/cyclophosphamide/etoposid e) was offered to patients with preceding standard dose the

233 Observation was offered to patients without symptoms or functional c

234 Pulmonary vein angiography and dilatation were offered to patients with severe (>70%) stenosis.

235 Post-treatment FP may be offered to people who did not undergo pretreatment FP

236 Pneumococcal vaccination should be offered to people with markers of hepatitis C virus i

237 In general, treatment should be offered to persons who have <350 CD4+ T cells/mm3 or

238 ings the possibility of preventative actions being offered to persons not currently targeted for scre

239 on HIV antigen/antibody assay; HCV screening was offered to persons born between 1945 and 1965.

240 mbination with endocrine therapy (ET) should be offered to postmenopausal patients, and to male patie

241 inhibitor (AI) and a CDK4/6 inhibitor should be offered to postmenopausal women with treatment-naive

242 alent human papillomavirus (HPV) vaccine has been offered to preadolescent girls via the National Imm

243 a "treatable fetal findings list," which can be offered to pregnant individuals undergoing fetal GS o

244 Finally, recommendations to authors are offered to promote accurate and unambiguous reportin

245 In severe cases, tracheal occlusion (TO) can be offered to promote lung growth.

246 ment arising from the proceedings of the 3D2 is offered to provide background to these issues and rec

247 ery strong view on this matter and apologies are offered to readers of the journal that this was not

248 ery strong view on this matter and apologies are offered to readers of the journal that this was not

249 Several explanations are offered to reconcile this observation with the fact

250 having a baby and appropriate support should be offered to reduce the psychological burden associated

251 for BC, tamoxifen (20 mg/d for 5 years) may be offered to reduce the risk of invasive ER-positive BC

252 .66%, tamoxifen (at 20 mg/d for 5 years) may be offered to reduce their risk.

253 tamoxifen (at 20 mg/d for up to 5 years) may be offered to reduce their risk.

254 Treatment was offered to residents who were >=5 years of age and n

255 Cytoreductive nephrectomy may be offered to select patients with kidney-in-place and f

256 splant is a lifesaving procedure that should be offered to selected patients with clear indications a

257 commend that genetic testing for IEIs should be offered to selected patients with warning signs for I

258 ion to transplantation, and transplant could be offered to selected patients, further research should

259 llogeneic hematopoietic stem cell transplant was offered to selected patients in first complete remis

260 STARHS was offered to sexually transmitted disease clinic patie

261 Evidence is offered to suggest that this concept may represent a

262 Thirdly, evidence is offered to suggest why such rises in sex ratio were n

263 Urine-Xpert Ultra are possible, both should be offered to support rapid diagnosis and treatment.

264 Similar evidence has been offered to support the idea that extinction causes

265 options, are first-line treatment and should be offered to symptomatic premenopausal women who do not

266 determination; what, if any, support should be offered to targeted clinicians; whether these inciden

267 itions (62%) and carrier status (62%) should be offered to the parents of a child with a medical cond

268 optimize treatment recommendations that can be offered to the patient.

269 f mutations leading to Mendelian disease has been offered to the medical community since 2011.

270 The database of coded studies and relations is offered to the scientific community to further advanc

271 Mass drug administration was offered to the entire population of Choiseul Provinc

272 wide cancer screening program in Germany; it was offered to the general population for individuals 55

273 Repeated education on avoiding eye rubbing was offered to the patient.

274 eatment in controlling the glaucoma, surgery was offered to the patient.

275 ncluded data on screening colonoscopies that were offered to the German general population 55 years o

276 ast transplant on July 31, 2000, 145 kidneys were offered to the participating centers and 48 transpl

277 on nutrition and chronic disease with cases were offered to the residents in family medicine, which

278 Ten acupuncture sessions were offered to the usual care group from weeks 12 throu

279 in the field and feed on the compound if it is offered to them in the laboratory.

280 Because a curative therapy can be offered to these patients (ie, bundle-branch ablation

281 Before an active surveillance strategy could be offered to these patients, clinically complete respon

282 h in terms of population benefit, and should be offered to those older than 50 years of age without h

283 It should also be offered to those receiving moderately myelosuppressiv

284 r susceptibility genes beyond BRCA1/2 should be offered to those with supportive family histories; te

285 nsure that cardiac resynchronization therapy is offered to those most likely to benefit.

286 nts, measles-mumps-rubella (MMR) vaccination was offered to those aged 6-14 months in municipalities

287 Educational links regarding donation were offered to those considering the new organ donor st

288 Hormone therapy should be offered to transgender adult patients, with levels ma

289 plantation, these HCV-viremic organs are now being offered to transplant candidates with or without p

290 [37-85] years) with late local toxic effects were offered to undergo HBOT (intervention arm), and 61

291 TS: In this quality improvement study, T-HIH was offered to veterans residing in Philadelphia, Pennsy

292 In this series, a laparoscopic approach was offered to virtually all patients to determine reaso

293 e, indicating that additional support should be offered to vulnerable groups as they return to school

294 BRCA1/2 testing should be offered to women who develop a second primary cancer

295 screening magnetic resonance imaging should be offered to women who meet high-risk criteria.

296 Preventive bilateral salpingo-oophorectomy is offered to women at high risk of ovarian cancer who c

297 agnetic resonance imaging (MRI) surveillance is offered to women with a pathogenic variant in the BRC

298 iants when universal BRCA1 and BRCA2 testing is offered to women with breast cancer.

299 at made up all 400 of the opportunities that were offered to women in the years surveyed.

300 d revised guidelines that hydroxyurea should be offered to youths aged 9 months and older with SCA re